Trials / Not Yet Recruiting
Not Yet RecruitingNCT07383805
Expression of Tim-3 on Neutrophils in Ankylosing Spondylitis
Expression of T Cell Immunoglobulin and Mucin-domain Containing Molecule 3 (Tim-3) on Neutrophils as an Indicator to Assess Disease Activity in Ankylosing Spondylitis Patients
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 81 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
1. To investigate the expression of Tim-3 on neutrophils in ankylosing spondylitis patients and its correlation with disease activity and inflammatory markers. 2. Association of Tim-3 with sacroiliac MRI findings and the hip inflammatory MRI scoring system (HIMRISS) .
Conditions
Timeline
- Start date
- 2026-06-01
- Primary completion
- 2026-09-01
- Completion
- 2029-09-01
- First posted
- 2026-02-03
- Last updated
- 2026-02-03
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07383805. Inclusion in this directory is not an endorsement.